Dietary supplements for treatment of endometriosis: A review

Main Article Content

Pınar Yalçın Bahat
Işıl Ayhan
Eda Üreyen Özdemir
Ümit İnceboz
Engin Oral

Keywords

dietary supplements, complementary therapies, endometriosis

Abstract

As search for optimal therapy continues for endometriosis, aid of dietary supplements is gaining attention. Supplements can be used for their anti-inflammatory, anti-oxidant, anti-proliferative and immune modulatory charactheristics. We reviewed the literature, evaluated and synthesized effects of vitamin D, zinc, magnesium, omega 3, propolis, quercetin, curcumin, N-acetylcysteine, probiotics, resveratrol, alpha lipoic acid, vitamin C, vitamin E, selenium and epigallocatechin-3-gallate. Based on results of in vitro, animal and human studies, it might be safe to say that dietary supplements can be used as a complementary treatment for endometriosis.

Downloads

Download data is not yet available.
Abstract 27 |

References

1. Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers. 2018 Jul 19;4(1):9.

2. Laganà, Antonio Simone, et al. "Stem cell trafficking during endometriosis: may epigenetics play a pivotal role?." Reproductive Sciences 25.7 (2018): 978-979.
3. Laganà, Antonio Simone, et al. "Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis." Medical hypotheses 103 (2017): 10-20.
4. Lagana, Antonio Simone, et al. "Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease." Gynecological Endocrinology 36.5 (2020): 441-444.
5. Laganà, Antonio Simone, et al. "The pathogenesis of endometriosis: molecular and cell biology insights." International journal of molecular sciences 20.22 (2019): 5615.

6. Johnson NP, Hummelshoj L, Consortium ftWESM, et al. Consensus on current management of endometriosis. Human Reproduction. 2013;28(6):1552-1568.
7. Holt VL, Weiss NS. Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology. 2000 Nov;11(6):654-9.

8. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020 Mar 26;382(13):1244-1256.

9. Laganà, Antonio Simone, et al. "Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside." (2017): 593-596.
10. Sansone, Anna, et al. "Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study." Archives of gynecology and obstetrics 298.4 (2018): 731-736.
11. Laganà, Antonio Simone, et al. "Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options." BioMed research international 2016 (2016).
12. Raffaelli, Ricciarda, et al. "Mesenteric vascular and nerve sparing surgery in laparoscopic segmental intestinal resection for deep infiltrating endometriosis." European Journal of Obstetrics & Gynecology and Reproductive Biology 231 (2018): 214-219.
13. DRI. Institute of Medicine, Food and Nutrition Board, Dietary Reference Intakes: energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. The National Academy Washington; 2005.
14. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril. 2001 Aug;76(2):223-31.
15. Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M, et al. Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial. Med Sci Monit. 2016 Dec 17;22:4960-4966.

16. Sassi F, Tamone C, D'Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients. 2018 Nov 3;10(11).
17. Akyol A, Şimşek M, İlhan R, et al. Efficacies of vitamin D and omega-3 polyunsaturated fatty acids on experimental endometriosis. Taiwan J Obstet Gynecol. 2016 Dec;55(6):835-839.
18. Harris HR, Chavarro JE, Malspeis S, et al. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013 Mar 1;177(5):420-30.
19. Qiu Y, Yuan S, Wang H. Vitamin D status in endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020 Jul;302(1):141-152.
20. Trumbo P, Yates AA, Schlicker S, et al. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Journal of the Academy of Nutrition and Dietetics. 2001;101(3):294.
21. Zaichick S, Zaichick V, Nosenko S, et al. Mass fractions of 52 trace elements and zinc/trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry. Biol Trace Elem Res. 2012 Nov;149(2):171-83.
22. Malavolta M, Piacenza F, Basso A, et al. Speciation of trace elements in human serum by micro anion exchange chromatography coupled with inductively coupled plasma mass spectrometry. Anal Biochem. 2012 Feb 1;421(1):16-25.
23. O'Connor JM. Trace elements and DNA damage. Biochem Soc Trans. 2001 May;29(Pt 2):354-7.
24. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):646-52.
25. Messalli EM, Schettino MT, Mainini G, et al. The possible role of zinc in the etiopathogenesis of endometriosis. Clin Exp Obstet Gynecol. 2014;41(5):541-6.
26. Lai GL, Yeh CC, Yeh CY, et al. Decreased zinc and increased lead blood levels are associated with endometriosis in Asian Women. Reprod Toxicol. 2017 Dec;74:77-84.
27. Singh AK, Chattopadhyay R, Chakravarty B, et al. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013 Dec;42:116-24.
28. Mier-Cabrera J, Aburto-Soto T, Burrola-Méndez S, et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol. 2009 May 28;7:54.
29. Ayuk J, Gittoes NJ. Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem. 2014 Mar;51(Pt 2):179-88.
30. Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013 May 1;4(3):378s-83s.
31. Sherwood RA, Rocks BF, Stewart A, et al. Magnesium and the premenstrual syndrome. Ann Clin Biochem. 1986 Nov;23 ( Pt 6):667-70.
32. Mathias JR, Franklin R, Quast DC, et al. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
33. D'Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest. 1992 Jun;89(6):1988-94.
34. Hoşgörler F, Kızıldağ S, Ateş M, et al. The Chronic Use of Magnesium Decreases VEGF Levels in the Uterine Tissue in Rats. Biol Trace Elem Res. 2020 Aug;196(2):545-551.
35. Spencer L, Mann C, Metcalfe M, et al. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer. 2009 Aug;45(12):2077-86.
36. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003 Jul 15;108(2):155-60.
37. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000 Jan;71(1 Suppl):343s-8s.
38. Camuesco D, Gálvez J, Nieto A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005 Apr;135(4):687-94.
39. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505.
40. Gazvani MR, Smith L, Haggarty P, et al. High omega-3:omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis. Fertil Steril. 2001 Oct;76(4):717-22.
41. Pereira F, Medeiros FDC, Rocha HAL, et al. Effects of omega-6/3 and omega-9/6 nutraceuticals on pain and fertility in peritoneal endometriosis in rats. Acta Cir Bras. 2019 May 6;34(4):e201900405.
42. Netsu S, Konno R, Odagiri K, et al. Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril. 2008 Oct;90(4 Suppl):1496-502.
43. Tomio K, Kawana K, Taguchi A, et al. Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS One. 2013;8(9):e73085.
44. Covens AL, Christopher P, Casper RF. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil Steril. 1988 Apr;49(4):698-703.
45. Signorile PG, Viceconte R, Baldi A. Novel dietary supplement association reduces symptoms in endometriosis patients. J Cell Physiol. 2018 Aug;233(8):5920-5925.
46. Nodler JL, DiVasta AD, Vitonis AF, et al. Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2020 May 26.
47. Hopeman MM, Riley JK, Frolova AI, et al. Serum Polyunsaturated Fatty Acids and Endometriosis. Reprod Sci. 2015 Sep;22(9):1083-7.
48. Parazzini F, Viganò P, Candiani M, et al. Diet and endometriosis risk: a literature review. Reprod Biomed Online. 2013 Apr;26(4):323-36.
49. Jurkiewicz-Przondziono J, Lemm M, Kwiatkowska-Pamuła A, et al. Influence of diet on the risk of developing endometriosis. Ginekol Pol. 2017;88(2):96-102.
50. Gregoris E, Stevanato R. Correlations between polyphenolic composition and antioxidant activity of Venetian propolis. Food Chem Toxicol. 2010 Jan;48(1):76-82.
51. Ryu S, Bazer FW, Lim W, et al. Chrysin leads to cell death in endometriosis by regulation of endoplasmic reticulum stress and cytosolic calcium level. J Cell Physiol. 2019 Mar;234(3):2480-2490.
52. Chakraborty S, Das K, Saha S, et al. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation. J Biol Chem. 2014 Oct 17;289(42):29074-85.
53. Jiménez-Osorio AS, García-Niño WR, González-Reyes S, et al. The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study. J Ren Nutr. 2016 Jul;26(4):237-44.
54. Nelson KM, Dahlin JL, Bisson J, et al. The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017 Mar 9;60(5):1620-1637.
55. Hendarto H, Yohanes Ardianta Widyanugraha M, Widjiati W. Curcumin improves growth factors expression of bovine cumulus-oocyte complexes cultured in peritoneal fluid of women with endometriosis. Int J Reprod Biomed (Yazd). 2018 Dec;16(12).
56. Zhang Y, Cao H, Yu Z, et al. Curcumin inhibits endometriosis endometrial cells by reducing estradiol production. Iran J Reprod Med. 2013 May;11(5):415-22.
57. Boroumand S, Hosseini S, Pashandi Z, et al. Curcumin-loaded nanofibers for targeting endometriosis in the peritoneum of a mouse model. J Mater Sci Mater Med. 2019 Dec 14;31(1):8.
58. Kizilay G, Uz YH, Seren G, et al. In vivo effects of curcumin and deferoxamine in experimental endometriosis. Adv Clin Exp Med. 2017 Mar-Apr;26(2):207-213.
59. Jelodar G, Azimifar A. Evaluation of serum cancer antigen 125, resistin, leptin, homocysteine, and total antioxidant capacity in rat model of endometriosis treated with Curcumin. Physiol Rep. 2019 Feb;7(4):e14016.
60. Jana S, Chakravarty B, Chaudhury K. Letrozole and curcumin loaded-PLGA nanoparticles: a therapeutic strategy for endometriosis. J Nanomed Biotherap Discov. 2014;4(123):10.4172.
61. Zhang Y, Cao H, Hu YY, et al. Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int J Mol Med. 2011 Jan;27(1):87-94.
62. Cao H, Wei YX, Zhou Q, et al. Inhibitory effect of curcumin in human endometriosis endometrial cells via downregulation of vascular endothelial growth factor. Mol Med Rep. 2017 Oct;16(4):5611-5617.
63. Vallée A, Lecarpentier Y. Curcumin and Endometriosis. International Journal of Molecular Sciences. 2020;21(7):2440.
64. Park S, Lim W, Bazer FW, et al. Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo. The Journal of nutritional biochemistry. 2019;63:87-100.
65. Cao Y, Zhuang M-f, Yang Y, et al. Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model. Evidence-Based Complementary and Alternative Medicine. 2014;2014.
66. Porpora MG, Brunelli R, Costa G, et al. A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evidence-based Complementary and Alternative Medicine. 2013;2013.
67. Pittaluga E, Costa G, Krasnowska E, et al. More than antioxidant: N-acetyl-L-cysteine in a murine model of endometriosis. Fertility and sterility. 2010;94(7):2905-2908.
68. Onalan G, Gulumser C, Mulayim B, et al. Effects of amifostine on endometriosis, comparison with N-acetyl cysteine, and leuprolide as a new treatment alternative: a randomized controlled trial. Archives of gynecology and obstetrics. 2014;289(1):193-200.
69. Agostinis C, Zorzet S, De Leo R, et al. The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis. Mediators Inflamm. 2015;2015:918089.
70. Lete I, Mendoza N, de la Viuda E, et al. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018;228:221-224.
71. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(9):1021.
72. Ata B, Yildiz S, Turkgeldi E, et al. The endobiota study: comparison of vaginal, cervical and gut microbiota between women with stage 3/4 endometriosis and healthy controls. Scientific reports. 2019;9(1):1-9.
73. Molina NM, Sola-Leyva A, Saez-Lara MJ, et al. New Opportunities for Endometrial Health by Modifying Uterine Microbial Composition: Present or Future? Biomolecules. 2020;10(4):593.
74. Rauf A, Imran M, Butt MS, et al. Resveratrol as an anti-cancer agent: A review. Critical reviews in food science and nutrition. 2018;58(9):1428-1447.
75. Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biological and Pharmaceutical Bulletin. 2012;35(3):273-279.
76. Chu M, Almagro L, Chen B, et al. Recent trends and comprehensive appraisal for the biotechnological production of trans-resveratrol and its derivatives. Phytochemistry Reviews. 2018;17(3):491-508.
77. Lousse J-C, Van Langendonckt A, Defrere S, et al. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed). 2012;4(1):23-40.
78. Taguchi A, Koga K, Kawana K, et al. Resveratrol enhances apoptosis in endometriotic stromal cells. American Journal of Reproductive Immunology. 2016;75(4):486-492.
79. Tekin YB, Guven S, Kirbas A, et al. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;184:1-6.
80. Kodarahmian M, Amidi F, Moini A, et al. The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecological Endocrinology. 2019;35(8):719-726.
81. Ozcan Cenksoy P, Oktem M, Erdem O, et al. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Gynecological Endocrinology. 2015;31(3):219-224.
82. Rudzitis-Auth J, Menger M, Laschke M. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Human reproduction. 2013;28(5):1339-1347.
83. Mendes da Silva D, Gross LA, Neto EdPG, et al. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. Journal of the Endocrine Society. 2017;1(4):359-369.
84. Pınar N, Soylu Karapınar O, Özcan O, et al. Effect of alpha‐lipoic acid on endometrial implants in an experimental rat model. Fundamental & clinical pharmacology. 2017;31(5):506-512.
85. De VL, Cagnacci A, Cappelli V, et al. Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis. Minerva ginecologica. 2019;71(3):191-195.
86. Caruso S, Iraci MS, Casella E, et al. Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid. Minerva ginecologica. 2015;67(5):413-419.
87. Sinclair A, Barnett A, Lunec J. Free radicals and antioxidant systems in health and disease. British journal of hospital medicine. 1990;43(5):334-344.
88. Brattin WJ, Glende Jr EA, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. Journal of free radicals in biology & medicine. 1985;1(1):27-38.
89. Thomas MJ. The role of free radicals and antioxidants: how do we know that they are working? Critical Reviews in Food Science & Nutrition. 1995;35(1-2):21-39.
90. Durak Y, Kokcu A, Kefeli M, et al. Effect of vitamin C on the growth of experimentally induced endometriotic cysts. Journal of Obstetrics and Gynaecology Research. 2013;39(7):1253-1258.
91. Erten OU, Ensari TA, Dilbaz B, et al. Vitamin C is effective for the prevention and regression of endometriotic implants in an experimentally induced rat model of endometriosis. Taiwanese Journal of Obstetrics and Gynecology. 2016;55(2):251-257.
92. Lu X, Wu Z, Wang M, et al. Effects of vitamin C on the outcome of in vitro fertilization-embryo transfer in endometriosis: A randomized controlled study. J Int Med Res. 2018 Nov;46(11):4624-4633.
93. Yao T, Degli Esposti S, Huang L, et al. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E. American Journal of Physiology-Gastrointestinal and Liver Physiology. 1994;267(3):G476-G484.
94. Murphy AA, Santanam N, Morales AJ, et al. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. The Journal of Clinical Endocrinology & Metabolism. 1998;83(6):2110-2113.
95. Liu F, He L, Liu Y, et al. The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis. Clin Exp Obstet Gynecol. 2013;40(3):372-376.
96. Zhao L, Zhao W, Ou Y. Correlation of the metabolism of oxygen free radical in ovary, uterine muscle and vein blood with the pathogenesis of endometriosis or endometrioma. Zhonghua fu chan ke za zhi. 2001;36(5):299-301.
97. Donabela FC, Andrade A, Rodrigues JK, et al. Serum markers of oxidative stress in infertile women with endometriosis and controls. Fertility and Sterility. 2010;94(4):S40.
98. Santanam N, Kavtaradze N, Murphy A, et al. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Translational Research. 2013;161(3):189-195.
99. Andrade AZ, Rodrigues JK, Dib LA, et al. [Serum markers of oxidative stress in infertile women with endometriosis]. Rev Bras Ginecol Obstet. 2010 Jun;32(6):279-85.
100. MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010 Feb 8;170(3):256-61.
101. Morgia G, Cimino S, Favilla V, et al. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study. Int Braz J Urol. 2013 Mar-Apr;39(2):214-21.
102. Hernández Guerrero CA, Bujalil Montenegro L, de la Jara Díaz J, et al. [Endometriosis and deficient intake of antioxidants molecules related to peripheral and peritoneal oxidative stress]. Ginecol Obstet Mex. 2006 Jan;74(1):20-8.
103. Laschke MW, Schwender C, Scheuer C, et al. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod. 2008 Oct;23(10):2308-18.
104. Xu H, Lui WT, Chu CY, et al. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009 Mar;24(3):608-18.
105. Ricci AG, Olivares CN, Bilotas MA, et al. Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 2013 Jan;28(1):178-88.
106. Matsuzaki S, Darcha C. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis. Hum Reprod. 2014 Aug;29(8):1677-87.
107. Wang CC, Xu H, Man GC, et al. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis. 2013 Jan;16(1):59-69.
108. Xu H, Becker CM, Lui WT, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril. 2011 Oct;96(4):1021-8.

Most read articles by the same author(s)